Restylane Lyft is intended to be used for facial tissue augmentation. It is recommended to be used for shaping the contours of the face, the correction of folds and for lip enhancement.
It should be injected into the deep layer of the dermis and/or the surface layer of the subcutis or in the submucosal layer of the lip. For facial areas with limited soft tissue support and soft tissue cover, e.g. the periorbital region, injection into the subcutaneous fatty tissue or supraperiostal administration are recommended.
The addition of lidocaine provides a pain relieving effect during treatment.
Disposable sterile 29G TW (thin-walled) needles are provided. In case a replacement needle is required a 27G needle should be used.
Alternatively, a sterile blunt cannula 23-25G can be used. The size and the length of the cannula will affect the force needed to extrude the gel. If a thinner cannula is used the resistance during injection may be too high resulting in an increased risk for leakage or separation of the cannula and syringe. The same considerations are applicable for needles.
(Formerly Restylane Perlane)
DD/Medfx and BFM are the sole preferred distributor for Galderma products within the UK. We work closely with Galderma to ensure the safety of their products, this includes providing them with certain information about who has purchased the products. Details of how Galderma will protect and process this information can be found in their privacy notice here https://tinyurl.com/DD-Galderma